Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3676551019 | Amlodipine besilate 10 mg and olmesartan medoxomil 20 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3676553016 | Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3676554010 | Amlodipine besylate 10 mg and olmesartan medoxomil 20 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Is a | Product containing amlodipine and olmesartan (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Amlodipine besilate (substance) | false | Inferred relationship | Some | ||
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Olmesartan medoxomil (substance) | false | Inferred relationship | Some | ||
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Is a | Amlodipine-containing product in oral dose form | false | Inferred relationship | Some | ||
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Is a | olmésartan médoxomil | false | Inferred relationship | Some | ||
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Olmesartan medoxomil (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 20 | false | Inferred relationship | Some | 1 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | This attribute specifies the numerator unit for the presentation strength of a product. | mg | false | Inferred relationship | Some | 1 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | This attribute specifies the denominator unit for the presentation strength of a product. | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Amlodipine besilate (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | dix | false | Inferred relationship | Some | 2 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | This attribute specifies the numerator unit for the presentation strength of a product. | mg | false | Inferred relationship | Some | 2 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | This attribute specifies the denominator unit for the presentation strength of a product. | Tablet (unit of presentation) | false | Inferred relationship | Some | 2 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Amlodipine besilate (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Amlodipine besilate (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | dix | false | Inferred relationship | Some | 1 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Olmesartan medoxomil (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Olmesartan medoxomil (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 20 | false | Inferred relationship | Some | 2 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Amlodipine besilate (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Is a | Product containing amlodipine and olmesartan in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Olmesartan medoxomil (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet | Is a | Product containing only amlodipine and olmesartan in oral dose form (medicinal product form) | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)